Compare Marathon Digital Holdings Inc (MARA) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marathon Digital Holdings Inc vs Mesoblast Limited — how do they compare? Marathon Digital Holdings Inc trades at $10.13 (market cap $3.83B), while Mesoblast Limited trades at $13.8 (market cap $1.75B). The key difference: Marathon Digital Holdings Inc is far larger — about 2.2× Mesoblast Limited's market cap, and Marathon Digital Holdings Inc is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Marathon Digital Holdings Inc for 22 Days and Mesoblast Limited for 14 Days on average.
| MARA | MESO | |
|---|---|---|
Market Cap | $3.83B | $1.75B |
Volume | 47,742,698 | 239,027 |
Sector | Financials | Health |
52-Week High | $22.84 | $20.96 |
52-Week Low | $6.73 | $13.19 |
Typical Hold Time | 22 Days | 14 Days |
Enterprise Value | $5.87B | $1.83B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MARA stock trades at $10.36, down 5.56% today, with a bearish technical signal despite oscillators showing some bullish momentum. The company reported significant losses with a net income margin of -429.71% in 2026, though valuation ratios appear attractive with P/E of 3.37 and EV/EBITDA of 3.31. Recent earnings have consistently missed expectations, with Q2 2026 EPS of -1.60 versus expected 0.17.
The outlook remains challenging due to persistent losses and negative cash flow from operations. Analyst consensus is divided with 45% buy ratings and a $13.25 price target, suggesting 28% upside potential. Key risks include execution challenges, competitive pressures, and reliance on financing activities to sustain operations.
MESO trades at $13.94, up 2.42% with bearish technical signals from moving averages. The company reported substantial revenue growth to $120 million in 2026 but remains unprofitable with a -47.82% net margin. Recent FDA approval for Ryoncil potency assay and completion of Phase 3 back pain trial represent significant operational milestones. Cash position remains strong at $161.16 million, though debt levels require monitoring.
While MESO shows promising revenue growth and pipeline progress, persistent losses and negative ROE present fundamental challenges. Analyst consensus leans bullish with 45% buy ratings, but technical indicators suggest near-term caution. The stock offers speculative growth potential contingent on successful commercialization and path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Marathon Digital Holdings Inc
Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
